Skip to main content

Plaintiff Withdraws Asbestos-In-Talc Claims On Trial Eve

Plaintiff Withdraws Asbestos-In-Talc Claims On Trial Eve

Plaintiff Withdraws Asbestos-In-Talc Claims On Trial Eve

Introduction

A plaintiff, who sued Johnson & Johnson for his alleged mesothelioma from asbestos exposure, agreed to dismiss his claims on the eve of a South Carolina trial for the talcum lawsuit. In his lawsuit, the plaintiff blamed that asbestos presence in J&J's and Colgate-Palmolive's talcum powder products caused his fatal cancer. Additionally, he also stated he came in contact with asbestos at the workplace while working with industrial products.

J&J will face trial proceedings this month in Los Angeles Superior Court and Middlesex County Superior Court for allegations over its talcum powder causing ovarian cancer when used for personal hygiene. Asbestos exposure in manufacturing plants and mines has caused hazardous side-effects to several workers. Lawsuits filed against various industries claim the owners of not adequately warning about the risks of asbestos exposure to the workers.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!